Vita Global Sciences Partners with Veeva to Streamline Clinical Data Management

Rhea-AI Summary

Veeva Systems (NYSE: VEEV) announced a partnership with Vita Global Sciences to enhance clinical data management through Veeva Vault EDC. This collaboration aims to streamline processes, improve patient and stakeholder experiences, and accelerate study builds. Kelly Forester, director of clinical data management at Vita Global Sciences, highlighted the goal of delivering impactful innovations. Future plans include integrating Veeva Clinical Database (CDB) and Veeva RTSM to further optimize trial data management and patient randomization. Jon Young from Veeva emphasized that these advancements will help Vita Global Sciences achieve faster, more accurate trials.

Positive

• Partnership with Vita Global Sciences to enhance clinical data management.
• Implementation of Veeva Vault EDC to simplify processes and improve study efficiency.
• Future integration of Veeva Clinical Database (CDB) and Veeva RTSM for better data aggregation and trial supply management.
• Potential for faster and more accurate clinical trials.

Negative

• None.

CRO will use Veeva Vault EDC to deliver a better experience to patients, research sites, and sponsors

PLEASANTON, Calif., June 19, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Vita Global Sciences is partnering with Veeva to modernize its clinical data management processes and improve collaboration with key trial stakeholders. With Veeva Vault EDC, the CRO is establishing a foundation for study efficiency and faster study builds. 

"Veeva Vault EDC allows us to simplify our processes while ensuring a seamless experience for patients, research sites, and sponsors," said Kelly Forester, director of clinical data management at Vita Global Sciences. "Partnering with Veeva advances our mission to deliver innovations that can profoundly impact patient lives."

The CRO will use Vault EDC to design and deliver complex studies for its sponsor clients. Looking ahead, Vita Global Sciences plans to add Veeva Clinical Database (CDB) to aggregate and clean data from all sources, and Veeva RTSM to randomize patients and optimize trial supply management. This ensures Vita Global Sciences can run the study clients want while gaining visibility and control of trial data. With modern clinical data management applications on a single platform, the company can reduce manual processes for improved accuracy and speed.

"Veeva Vault EDC will help advance Vita Global Sciences processes as they move toward the future of clinical trials," said Jon Young, director, Veeva Vault Clinical Data Management strategy. "By establishing a clinical data foundation, Vita Global Sciences can accelerate study builds and manage changes with no downtime for faster trials that can improve patient outcomes."

Vault EDC is part of Veeva Vault Clinical Data Management, bringing together EDC and Veeva CDB for next-generation clinical data management. To learn more, visit veeva.com/VaultClinicalDataManagement.

About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.

Veeva Forward-looking Statements
This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended April 30, 2024, which you can find here (a summary of risks which may impact our business can be found on pages 35 and 36), and in our subsequent SEC filings, which you can access at sec.gov.

Contact:
Deivis Mercado Veeva Systems 925-226-8821 deivis.mercado@veeva.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/vita-global-sciences-partners-with-veeva-to-streamline-clinical-data-management-302175454.html

SOURCE Veeva Systems

FAQ

What is the recent partnership between Veeva Systems and Vita Global Sciences about?

The partnership aims to modernize clinical data management processes using Veeva Vault EDC, enhancing efficiency and stakeholder collaboration.

How will Veeva Vault EDC benefit Vita Global Sciences?

Veeva Vault EDC will simplify processes, improve accuracy, speed up study builds, and enhance patient and stakeholder experiences.

What are the future plans for Vita Global Sciences and Veeva Systems?

Future plans include integrating Veeva Clinical Database (CDB) and Veeva RTSM to optimize trial data management and patient randomization.

How will the partnership between Vita Global Sciences and Veeva Systems impact clinical trials?

The partnership aims to accelerate study builds, manage changes without downtime, and improve patient outcomes through faster and more accurate trials.

What is Veeva Vault EDC?

Veeva Vault EDC is a clinical data management application that simplifies processes, enhances accuracy, and accelerates study builds for clinical trials.